Delivery Order SPE2DB22D1041-SPE2DB24FUCM2

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D2006|SPE2DB25FV7CD, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,360.66 firm fixed-price delivery order is for the supply of 60 counts of 300 mg Rifampin capsules. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,545.11 firm fixed-price delivery order is for the supply of 60 count bottles of 300 mg Rifampin capsules. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,990.72 firm fixed-price delivery order is for the supply of 60 capsules of 300 mg Rifampin, a medication used to treat certain bacterial infections. The contract has an ultimate completion date of March 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,366.09 firm fixed-price delivery order is for the supply of 60 capsules of Rifampin 300 mg, a medication used to treat certain bacterial infections. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,841.06 Firm Fixed Price contract is for the delivery of 60 count bottles of 300 mg rifampin capsules. The contract has a period of performance through May 29, 2025 and is not a set-aside award. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,297.32 delivery order contract is for the supply of Rifampin 300 mg capsules, a medication used to treat various bacterial infections. The contract has an ultimate completion date of June 27, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,025.41 firm fixed-price delivery order is for the supply of 4,566,133,790 units of 300 mg Rifampin capsules. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,341.59 Firm Fixed Price Delivery Order contract is for the supply of 60 capsules of 300 mg Rifampin, a medication used to treat certain bacterial infections. The contract has an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,934.30 firm fixed-price delivery order (SPE2DB20D1004|SPE2DB23FG6D1) is for the supply of Rifampin 300 mg capsules. The contract has an ultimate completion date of September 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,288.96 firm fixed-price delivery order contract is for the supply of 60 capsules of 300 mg Rifampin, a critical antibiotic medication. The contract has an ultimate completion date of December 5, 2024 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUCM2
    Delivery Order

This federal contract award, with ID SPE2DB22D1041|SPE2DB24FUCM2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,886.99 firm fixed-price delivery order is for the supply of 60 count packages of 300 mg Rifampin capsules, with a completion date of July 9, 2024.

Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely part of that larger IDC, enabling efficient government procurement of essential pharmaceutical products to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:08 AM